Louise Brot Christensen

Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease: clinical outcomes in real-world patients from the DANBIO registry

A. Loft, J. K. Pedersen, F. Mehnert, 2022, RMD Open.